dopamimetic
Bluelighter
- Joined
- Mar 21, 2013
- Messages
- 2,070
There has been much recent interest in the use of ketamine as a ‘rapidly acting’ antidepressant. However in this context the time-of-onset is still around 2 h, and the duration of antidepressant effect lasts about a week. These effects clearly occur long after the drug has been eliminated from the body – which is indicative of a ketamine-induced signalling cascade.61 The putative mechanisms have been reviewed in detail by Duman and co-workers4; in brief they suggest that the ketamine at low doses actually increases glutamate neurotransmission by both increased glutamate release and increased AMPA receptor expression and insertion into the synaptic plate. This causes secondary increased BDNF release, and hence activation of ERK signalling which then stimulates mammalian target of rapamycin (mTOR) – a kinase that controls protein translation – and thus via a complex signalling path, leads to increased synaptic protein expression (GluR1) and increased insertion and density of synapses – leading to increased structural connectivity between neurons, particularly in the pre-frontal cortex. (from here)
Now we have people who are 'truly' depressed in the sense of too less overall excitatory activity. They will get this para-instant effect when the ketamine wears off. But we also have others, like me, who have a somewhat disrupted glutamate system with overactivity on the one side and under activity on the other. Probably this hits mostly people who are very sensitive to stress, emotionally 'overly sensible', inattentive ADD partially.
Here actually a constant modulation of glutamate is required. I get most out of a combination of these downstream effects but while being on a low actual NMDA blockade, offering some kind of 'distance' to all this sensory input, overwhelming emotions and impulse control problems, anxiety etc. that in the end cause the depressive state.
What are the implications of this? Riluzole certainly looks promising. But will there be tolerance development to chronic low NMDA antagonism over time, eventually making things worse or not?
One thing to watch out for seems to be the increased oxidative stress many NMDA antagonists cause, which is suggested to be one of the major factors for PCP / ketamine-induced psychosis, but this could maybe be managed by inhibiting the NADPH oxidase or just taking enough of N-acetylcysteine.